Related Experiment Video
Updated: May 25, 2026

08:47
Synthesis and Bioconjugation of Thiol-Reactive Reagents for the Creation of Site-Selectively Modified Immunoconjugates
Published on: March 6, 2019
A new chitosan-thymine conjugate: synthesis, characterization and biological activity
Santosh Kumar1, Joonseok Koh, Hyerim Kim
1Department of Textile Engineering, Konkuk University, Seoul 143-701, South Korea.
International Journal of Biological Macromolecules
|January 31, 2012
Summary
A new chitosan-thymine conjugate shows promising antimicrobial and anti-cancer properties. This novel biomaterial effectively combats bacteria and fungi while inhibiting liver cancer cell growth without harming healthy cells.
Area of Science:
- Biomaterials Science
- Medicinal Chemistry
- Antimicrobial Research
Background:
- Chitosan, a biopolymer, possesses inherent antimicrobial properties.
- Conjugation with nucleobases like thymine is explored to enhance chitosan's therapeutic potential.
- Nucleobase-modified biomaterials offer novel avenues for biomedical applications.
Purpose of the Study:
- To synthesize and characterize a novel chitosan-thymine conjugate.
- To evaluate the antimicrobial activity of the synthesized conjugate against various pathogens.
- To assess the anti-cancer efficacy and cytotoxicity of the conjugate on liver cancer cells and normal cells.
Main Methods:
- Synthesis of chitosan-thymine conjugate via reaction with thymine-1-yl-acetic acid and acylation.
- Characterization using Fourier-transform infrared spectroscopy (FTIR), X-ray diffraction (XRD), proton nuclear magnetic resonance ((1)H NMR), thermogravimetric analysis (TGA), and scanning electron microscopy (SEM).
- Microbiological screening against Escherichia coli, Staphylococcus aureus, and Aspergillus niger; cytotoxicity assays on HepG2 and NIH 3T3 cells.
Main Results:
- Successful synthesis and characterization of the chitosan-thymine conjugate confirmed by spectroscopic and analytical techniques.
- Demonstrated significant antimicrobial activity against tested bacteria (E. coli, S. aureus) and fungi (A. niger).
- Showed dose-dependent inhibition of human liver cancer cell (HepG2) proliferation with no observed toxicity in mouse embryonal fibroblast cells (NIH 3T3).
Conclusions:
- The synthesized chitosan-thymine conjugate exhibits potent antimicrobial and selective anti-cancer activities.
- This novel conjugate represents a promising candidate for developing new therapeutic agents in biomedical applications.
- Chitosan-nucleobase conjugates offer a versatile platform for enhanced biological functionalities.
